The Ustekinumab market was valued at USD 11.40 Billion in 2023 and is expected to reach USD 18.03 Billion by 2031, growing at a CAGR of 5.9% (2024-2031). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.